Delivery Order SPE2DB20D1110-SPE2DB25FK20H
- Not listed
- The Defense Logistics Agency awarded a $1,218.07 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Xtampza ER 27 mg capsules (100-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Xtampza ER 36 mg capsules (100-count units) with a ceiling value of $8,590.87. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a competitively awarded contract with no set-aside designation. The award is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,141.74 for XTAMPZA ER 13.5 mg capsules (100 count) on June 18, 2025, with an ultimate completion date of June 20, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xtampza ER 27 mg capsules (100-count units) on September 12, 2025, with a ceiling value of $1,092.43. This firm fixed price delivery order has an ultimate completion date of September 15, 2025, and represents a non-competitive award under a larger contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's Conshohocken, Pennsylvania facility, which serves as the company's...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order for 36mg Xtampza ER capsules valued at $6,176.76 on September 25, 2025, with completion scheduled for September 26, 2025. This competitive, firm fixed-price delivery order was issued without a set-aside designation and represents a direct fulfillment of pharmaceutical supply needs for the federal military healthcare system. The vendor, headquartered in Conshohocken, Pennsylvania, serves as...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,085.35 for XTAMPZA ER 18 mg capsules (100-count units) on July 11, 2025, with an ultimate completion date of July 14, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $1,538.92 to AmerisourceBergen Drug Corp for XTAMPZA ER 36 mg capsules (100 count), with performance in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order was issued on August 5, 2025, with an ultimate completion date of August 6, 2025. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete openly for federal medical procurement requirements....
- The Defense Logistics Agency awarded a delivery order valued at $1,703.99 to AmerisourceBergen Drug Corp for 100 capsules of Xtampza ER 36 mg, a long-acting opioid pain medication. The contract was competitively awarded with no set-aside designation, utilizing firm fixed pricing under a delivery order contract type. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,299.87 to AmerisourceBergen Drug Corp for XTAMPZA ER CAPS 13.5MG, a pharmaceutical product. The contract was competitively awarded without a set-aside designation on April 23, 2025, with an ultimate completion date of April 24, 2025. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. The award employs firm fixed price terms, typical of delivery orders...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for XTAMPZA ER 18 mg capsules (100-count packages) valued at $6,281.84 under a firm fixed-price contract type. The award was made on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK20HDelivery Order
The Defense Logistics Agency awarded a $1,344.17 delivery order to AmerisourceBergen Drug Corp on June 13, 2025, for the supply of Xtampza ER 36 mg capsules (100-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 16, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was selected through open competition to fulfill this pharmaceutical requirement. As a prime contractor on the DLA's global pharmaceutical support vehicle, AmerisourceBergen demonstrates capability across a broad spectrum of medical products and therapeutic domains serving military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers. The contract supports the ongoing pharmaceutical supply needs of the federal government, with deliverables expected within three days of award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 6/13/25 |